Therapeutic Solutions International, Inc.
TSOI · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $4,422 | $3,609 | $4,349 | $3,803 |
| - Cash | $9 | $8 | $53 | $28 |
| + Debt | $930 | $962 | $927 | $888 |
| Enterprise Value | $5,342 | $4,563 | $5,222 | $4,663 |
| Revenue | $20 | $20 | $22 | $24 |
| % Growth | -1.7% | -8.3% | -8.5% | – |
| Gross Profit | $15 | $13 | $14 | -$165 |
| % Margin | 77.6% | 66.4% | 65.7% | -693.9% |
| EBITDA | -$1,852 | -$313 | -$598 | -$302 |
| % Margin | -9,417.6% | -1,562.7% | -2,742.1% | -1,267.5% |
| Net Income | -$1,008 | -$390 | -$585 | -$427 |
| % Margin | -5,123% | -1,949.7% | -2,682.4% | -1,793.7% |
| EPS Diluted | -0 | -0 | -0 | -0 |
| % Growth | -100% | 0% | 0% | – |
| Operating Cash Flow | $71 | -$143 | -$206 | -$206 |
| Capital Expenditures | $0 | $0 | $0 | -$16,142 |
| Free Cash Flow | $71 | -$143 | -$206 | -$16,348 |